Legal Opinion
Amos v. Biogen Idec Inc.
District Court, W.D. New York
Decided April 10, 2017No. 13-CV-6375 TPublishedCited by 13 opinions
1Opinion of the Court
DECISION and ORDER
MICHAEL A. TELESCA, United States District Judge
INTRODUCTION
Plaintiff Gregory A. Amos (“plaintiff”), the widower of Andrea R. Amos (“Mrs. *693Amos”) and administrator of her estate, brings this wrongful death action against defendants Biogen Idee Inc., (“Biogen”) and Elan Pharmaceuticals, Inc. (“Elan”) (collectively “defendants”), alleging that Mrs. Amos died as the direct result of taking the prescription drug Tysabri, which was developed, marketed, and sold by the defendants. Specifically, plaintiff claims that Mrs. Amos’ use of Tysabri caused her to develop a fatal infection…
2Cases cited14 opinions
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Scott v. HarrisSupreme Court of the United States · 2007
- Tolan v. CottonSupreme Court of the United States · 2014
- Wyeth v. LevineSupreme Court of the United States · 2009
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
9 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- Byrd v. Janssen Pharm., Inc.District Court, N.D. New York · 2018
- Rinder v. Merck Sharp & Dhome Corp.Appellate Court of Illinois · 2019
- Boris v. Atrium Medical CorporationDistrict Court, S.D. New York · 2020
- Bustamante v. Atrium Medical CorporationDistrict Court, S.D. New York · 2020
- Cosh v. Atrium Medical CorporationDistrict Court, S.D. New York · 2021
8 more not listed; retrieve them via the Exa API.